Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yanti De Visser"'
Autor:
Maaike Van Trimpont, Amanda M. Schalk, Yanti De Visser, Hien Anh Nguyen, Lindy Reunes, Katrien Vandemeulebroecke, Evelien Peeters, Ying Su, Hyun Lee, Philip L. Lorenzi, Wai-Kin Chan, Veerle Mondelaers, Barbara De Moerloose, Tim Lammens, Steven Goossens, Pieter Van Vlierberghe, Arnon Lavie
Publikováno v:
Haematologica, Vol 108, Iss 2 (2022)
Asparagine is a non-essential amino acid since it can either be taken up via the diet or synthesized by asparagine synthetase. Acute lymphoblastic leukemia (ALL) cells do not express asparagine synthetase or express it only minimally, which makes the
Externí odkaz:
https://doaj.org/article/84eb300b22bd45b4b1a3b5c9f6e122b0
Autor:
Florian J Groelly, Manuela Porru, Jutta Zimmer, Hugo Benainous, Yanti De Visser, Anastasiya A Kosova, Serena Di Vito, Violeta Serra, Anderson Ryan, Carlo Leonetti, Alejandra Bruna, Annamaria Biroccio, Madalena Tarsounas
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 3, Pp n/a-n/a (2022)
Abstract The cells with compromised BRCA1 or BRCA2 (BRCA1/2) function accumulate stalled replication forks, which leads to replication‐associated DNA damage and genomic instability, a signature of BRCA1/2‐mutated tumours. Targeted therapies again
Externí odkaz:
https://doaj.org/article/02c619b0acf544c3b51f32c37322ca42
Autor:
Maaike Van Trimpont, Evelien Peeters, Yanti De Visser, Amanda M. Schalk, Veerle Mondelaers, Barbara De Moerloose, Arnon Lavie, Tim Lammens, Steven Goossens, Pieter Van Vlierberghe
Publikováno v:
CANCERS
Simple Summary L-asparaginase (L-ASNase) therapy is key for achieving the very high cure rate of pediatric acute lymphoblastic leukemia (ALL), yet its use is mostly confined to this indication. One main reason preventing the expansion of today's FDA-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b13686d90988e44e96ce006757dcb3a
https://hdl.handle.net/1854/LU-8740527
https://hdl.handle.net/1854/LU-8740527
Autor:
Yanti De Visser, Dena Panovska, Basiel Cole, Lotte Hermans, Asier Antoranz Martinez, Pouya Nazari, Maaike Van Trimpont, Marleen Derweduwe, Annelies Claeys, Steven De Vleeschouwer, Lien Solie, Paul Clement, Raf Sciot, Michiel Verfaillie, Thomas Daenekindt, Sven Bamps, Pieter Van Vlierberghe, Frederik De Smet
Publikováno v:
Neuro-Oncology. 24:vii7-vii7
Glioblastoma remains a highly malignant and intrinsically resistant brain tumor. Despite intensive research through which numerous potential druggable targets were identified, virtually all clinical trials of the past 20 years failed to improve the o
Autor:
Groelly, Florian J, Porru, Manuela, Zimmer, Jutta, Benainous, Hugo, De Visser, Yanti, Kosova, Anastasiya A, Di Vito, Serena, Serra, Violeta, Ryan, Anderson, Leonetti, Carlo, Bruna, Alejandra, Biroccio, Annamaria, Tarsounas, Madalena
Publikováno v:
EMBO Molecular Medicine; 3/7/2022, Vol. 14 Issue 3, p1-22, 22p
Autor:
Van Trimpont, Maaike1,2,3 (AUTHOR) maaike.vantrimpont@ugent.be, Peeters, Evelien1,3,4 (AUTHOR) evelien.peeters@ugent.be, De Visser, Yanti1,2,5 (AUTHOR) yanti.devisser@kuleuven.be, Schalk, Amanda M.6 (AUTHOR) aschalk@uic.edu, Mondelaers, Veerle7 (AUTHOR) veerle.mondelaers@uzgent.be, De Moerloose, Barbara1,7,8 (AUTHOR) barbara.demoerloose@uzgent.be, Lavie, Arnon6,9 (AUTHOR) lavie@uic.edu, Lammens, Tim1,7,8 (AUTHOR) tim.lammens@ugent.be, Goossens, Steven1,3 (AUTHOR) steven.goossens@ugent.be, Van Vlierberghe, Pieter1,2 (AUTHOR) pieter.vanvlierberghe@ugent.be
Publikováno v:
Cancers. Feb2022, Vol. 14 Issue 4, p902. 1p.